• Featured Product
  • KD/KO Validated

ZNF385A Polyclonal antibody

ZNF385A Polyclonal Antibody for WB, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse

Applications

WB, IHC, IF/ICC, ELISA

Conjugate

Unconjugated

Cat no : 26288-1-AP

Synonyms

HZF, Retinal zinc finger protein, RZF, ZFP385, zinc finger protein 385A, ZNF385, ZNF385A



Tested Applications

Positive WB detected inHeLa cells
Positive IF/ICC detected inHaCaT cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

26288-1-AP targets ZNF385A in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Cited Reactivityhuman, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen ZNF385A fusion protein Ag23577
Full Name zinc finger protein 385A
Observed Molecular Weight 45-50 kDa
GenBank Accession NumberBC029752
Gene Symbol ZNF385A
Gene ID (NCBI) 25946
RRIDAB_2880464
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for ZNF385A antibody 26288-1-APDownload protocol
IF protocol for ZNF385A antibody 26288-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Int J Mol Sci

ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma

Authors - Qihang Peng
  • KD Validated
human,mouseWB,IHC

J Proteome Res

Quantitative Proteomics Reveal the Mechanism of MiR-138-5p Suppressing Cervical Cancer via Targeting ZNF385A

Authors - Qihang Peng
  • KD Validated